P

Panther Life Sciences

MAP-based skin therapy delivery platform

Director – Manufacturing Operations

Full-TimeUpdated on 10/1/2026
$220k - $260k/yr+ Stock options
Expert
New York, NY, USA
HybridBased in New York City; approximately 10%–30% travel required.

About the job

Requirements
  • Proven experience scaling a product from research and development to commercial manufacturing in a regulated environment.
  • Experience overseeing manufacturing operations for a Class II or III medical device or equivalent regulated product.
  • Hands-on experience scaling production volumes significantly, such as 10 times or more.
  • Direct experience working with contract development and manufacturing organization partners, including selection, onboarding, and technology transfer.
  • Experience managing supply chain, logistics, inventory, and fulfillment operations.
  • Familiarity with Quality Management Systems in regulated environments.
  • Demonstrated ability to lead technology transfer and process scale-up.
  • Experience with manufacturing cost modeling and financial planning.
  • Direct people management experience.
Responsibilities
  • Serve as the primary relationship owner and day-to-day point of contact for contract development and manufacturing organization partners.
  • Lead technology transfer from research and development to clinical and commercial manufacturing.
  • Oversee late-stage clinical and commercial production across product lines.
  • Drive manufacturing performance metrics, including yield, throughput, and product quality.
  • Support partner selection and onboarding, including process validation and scale-up.
  • Build and manage supply chain, logistics, fulfillment, and inventory operations.
  • Own material sourcing and supplier relationships.
  • Identify critical dependencies and build supplier redundancy to mitigate risk.
  • Build the manufacturing line from the ground up, with a path from approximately 10,000 to 1 million units per month.
  • Drive automation, process optimization, and line redesign as production scales.
  • Own manufacturing cost modeling and financial planning for operations.
  • Develop sourcing strategy and budget frameworks in partnership with finance and leadership.
  • Establish systems and processes to support future team growth and internal manufacturing capabilities.
  • Ensure manufacturing quality, regulatory compliance, and adherence to Quality Management Systems.
  • Partner cross-functionally with the chief technology officer, formulation, device, and quality teams.
  • Contribute to customer satisfaction through reliable product delivery and issue resolution.
Desired Qualifications
  • Experience with combination products (drug and device), such as auto-injectors, EpiPens, nasal sprays, or microarray-based systems.
  • Background in Material Science & Technology Transfer (MSNT).
  • Experience scaling production to high-volume output of 100,000 or more units per month.
  • Experience across both cosmetic and medical device products.
  • Experience with automation and line redesign in a manufacturing scale-up context.
  • Background in customer support or customer-facing operations within manufacturing.
  • Experience managing managers or building multi-layered organizations.
  • Strong systems orientation with experience implementing or optimizing operational infrastructure.

About the company

Panther Life Sciences uses a patented microarray patch (MAP) and software-enabled engineering to deliver shelf-stable skin treatments directly to consumers worldwide. Treatments are loaded onto the MAP patch and applied to the skin to release doses, with shelf-stable formulations allowing global distribution as part of an end-to-end platform. Its MAP technology and platform differentiate it by enabling partnerships across skincare, pharma, biotech, and other industries, not just a single product. The goal is to reshape healthcare by making skin-based treatments easier to access globally and by providing a versatile platform for collaboration and delivery.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2023

Get referred to Panther Life Sciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 9, 2026 CEO Mounir Hanana brings Amazon Business scaling and operations experience.
  • January 2026 BioForge partnership and 2026 manufacturing success support credible commercialization.
  • Panther can expand from cosmetics into dermatology and immune therapies using the same platform.

What critics are saying

  • Revenue arrives only after 2027 SmartPatch deployment, delaying validation and cash generation.
  • Consumer cosmetics and aesthetics commercialization risks distraction before therapeutic reimbursement or FDA pathways.
  • If SmartPatch manufacturing economics slip, Panther loses its core thesis and partner appeal.

What makes Panther Life Sciences unique

  • Panther’s SmartPatch aims to replace needles with shelf-stable, self-applied microarray patches.
  • Licensed University of Pittsburgh and Carnegie Mellon science underpins its skin-delivery platform.
  • BioForge validated at-scale MAP manufacturing, a rare barrier for microarray-patch startups.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

Hybrid Work Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

↑ 29%

1 year growth

↑ 29%

2 year growth

↑ 29%
Today in New York
Sep 9th, 2026
Panther Life Sciences appoints Mounir Hanana as Chief Executive Officer.

Panther Life Sciences appoints Mounir Hanana as Chief Executive Officer. Hanana joins as Panther begins commercializing its SmartPatch(TM) platform, starting with cosmetics & medical aesthetics and expanding to therapeutic applications. Its team has built a unique, powerful technology capable of transforming both consumer and medical markets." - Mounir Hanana, CEO of Panther Life Sciences NEW YORK, NY, UNITED STATES, September 9, 2026 /EINPresswire.com/ - Panther Life Sciences today announced the appointment of Marcus "Mounir" Hanana as Chief Executive Officer. Founder Carlos Bhola will continue as Executive Chairman, partnering closely with Hanana as Panther commercializes its SmartPatch(TM) platform across high-growth health, wellness and therapeutic markets, including dermatology and aesthetic applications. "Beginning in late 2023 with a small, agile team, we combined innovations in skin biology with advanced engineering expertise to develop a delivery platform for next-generation treatments. We are now ready to deploy our SmartPatch, in 2027, which requires go-to-market and commercialization capabilities," said Bhola. "We were intentional in our search for a partner with a track record of deploying global technology platforms, scaling manufacturing, and commercializing innovation - and we found that in Mounir. I am excited by what Panther will accomplish under Mounir's direction and am looking forward to closely partnering with him." Hanana brings 25 years of global leadership experience across Procter & Gamble and Amazon. During his career, he has led initiatives ranging from several hundred million dollars in revenue to large global multibillion-dollar businesses, combining expertise in manufacturing, commercialization, technology platforms and operational scale. At Procter & Gamble, he helped bring consumer products from development to market through world-class manufacturing, supply chains and commercial organizations. At Amazon, he led large global technology businesses, most recently serving as CFO of Amazon Business, one of the company's fastest-growing global businesses. Together, these experiences span consumer products, advanced manufacturing, global technology platforms and operational excellence - capabilities critical for Panther's next phase of commercialization. "Having spent much of my career building and scaling global businesses, I know a category-defining opportunity when I see one," said Hanana. "That is why I joined Panther. Our team has built a unique, powerful technology capable of transforming both consumer and medical markets. I am looking forward to partnering with Carlos as we build the operational foundation to bring this platform to consumers at scale." With Hanana leading Panther's operations, commercialization and organizational growth, Bhola will focus on leading strategy, product vision and corporate development. About Panther Life Sciences Panther Life Sciences is building the leading skin-powered delivery platform for health, wellness and therapeutics. Its proprietary intradermal SmartPatch(TM) precisely delivers treatments through the skin, unlocking the skin as a scalable gateway for care. Panther's AI-based platform accelerates product development and personalizes treatment and care, resulting in compelling provider and consumer experiences. Panther is led by a team of successful entrepreneurs and operators and is advised by leading scientific experts. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Today in New York do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Pitt Review
Jun 2nd, 2026
Biomanufacturing and partnerships drive innovation in Greater Hazelwood.

Biomanufacturing and partnerships drive innovation in Greater Hazelwood. Jun 2, 2026 Biomanufacturing, workforce development, and community partnerships are shaping the future of Greater Hazelwood, a neighborhood along the Monongahela River where a former brownfield is being transformed into a sustainability, research, and innovation tech hub, according to a June 2 report. At an event in late April, Heidi Ward, who leads the University of Pittsburgh's Greater Hazelwood Neighborhood Commitment; Ian Johnson, director of life sciences at BioForge; and Rosta Farzan, associate dean for Engaged Scholarship at Pitt's School of Computing and Information Sciences, discussed efforts to connect neighborhood priorities with opportunities in the life sciences sector. The event was part of the Pitt Alumni Association's Pitt Academy speaker series. Vice Chancellor for External Relations Lina Dostillio said, "The Plan for Pitt 2028 calls for us to be a University that is welcoming and engaged, place-based, committed to the communities of Western Pennsylvania and striving to have a positive effect on the world around us. We are a partner in solving the real problems that folks are facing. It means we are showing up every day to expand workforce development opportunities, and our research is opening new doors. We are an economic anchor, as well." The discussion took place at the restored Roundhouse - a former J&L Steel mill facility now serving as coworking space - highlighting how investment has shifted from industrial steel production toward technology-driven innovation at Hazelwood Green. Ward described this transformation: "This building is a metaphor for what's possible when research, industry and neighborhood partnerships all work together to shape Pittsburgh's next chapter." Johnson detailed BioForge's role in helping researchers and startups address manufacturing challenges. He explained that BioForge partners with academic innovators on projects such as Furnace - an mRNA brokerage platform - and microneedle patch technology developed by Pitt-connected researchers. Johnson also noted that Panther Life Sciences relocated operations to Pittsburgh after working with BioForge. Ward highlighted more than 25 years of collaboration between Pitt and Greater Hazelwood but said recent developments prompted questions about ensuring local residents benefit from new innovations. In response, Pitt launched initiatives including middle school biotechnology activities and public science events as well as piloting a Life Sciences Bridge Program - a paid workforce development initiative introducing young adults without college degrees to careers in biotechnology. Farzan discussed community engagement efforts involving local organizations like Center of Life and Hazelwood Initiative. One project focused on air quality monitoring with resident participation guiding sensor placement while students assisted with data collection. Farzan said successful collaboration requires patience: "That is actually how we learn a lot about how to best solve these problems and build technologies that are actually better for everyone." The panel emphasized that progress depends on long-term relationships built through trust between institutions like Pitt and neighborhood residents.

EIN Presswire
Mar 5th, 2025
Panther Life Sciences to Partner with BioForge to Accelerate Development and Manufacturing of Microarray Patches

Partnership to Deliver More Effective Treatments for Skin-Based and Immune-Mediated Applications

Medical Design Briefs
Feb 26th, 2025
Panther Life Sciences Partners with BioForge to Accelerate Development and Manufacturing of Microarray Patches

Panther Life Sciences partners with BioForge to accelerate development and manufacturing of microarray patches.